<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35357272</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1525-6049</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>44</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Renal failure</Title>
          <ISOAbbreviation>Ren Fail</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The spectrum of renal diseases with lupus-like features: a single-center study.</ArticleTitle>
        <Pagination>
          <StartPage>581</StartPage>
          <EndPage>593</EndPage>
          <MedlinePgn>581-593</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/0886022X.2022.2057862</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">A subset of patients without overt systemic lupus erythematosus (SLE) present with biopsy findings typically seen in lupus nephritis (LN). Although a minority eventually develops SLE, many do not. It remains unclear how to classify or treat these patients. Our study attempted to further understand the clinical and pathological characteristics of cases with lupus-like nephritis (LLN).</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Among 2700 native kidney biopsies interpreted at University of Rochester Medical Center (URMC) from 2010 to 2019, we identified 27 patients with biopsies showing lupus-like features (LL-fx) and 96 with LN. Of those with LL-fx, 17 were idiopathic LLN and 10 were associated with a secondary etiology (e.g., infection/drugs).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">At the time of biopsy, the LLN-group tended to be slightly older (44 <i>vs.</i> 35), male (58.8 <i>vs.</i> 17.7%, <i>p</i> = .041), and Caucasian (47.0 <i>vs.</i> 28.1%, <i>p</i> = .005). Chronic kidney disease was the most common biopsy indication in LLN (21.4 <i>vs.</i> 2.8%, <i>p</i> = .001). Both LN and LLN presented with nephrotic-range proteinuria (mean 5.73 <i>vs</i>. 4.40 g/d), and elevated serum creatinine (mean 1.66 <i>vs</i>. 1.47 mg/dL). Tubuloreticular inclusions (TRIs; <i>p</i> &lt; .001) and fibrous crescents (<i>p</i> = .04) were more often seen in LN, while more tubulointerstitial scarring was seen in LLN (<i>p</i> = .011). At mean follow-up of 1684 d (range: 31-4323), none of the LLN patients developed ESRD. A subset of both LN and cases with LL-fx overlapped with other autoimmune diseases.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Lupus-like pathologic features are seen in a wide array of disease processes. The findings suggest that LLN may be a manifestation of an autoimmune process that overlaps with SLE.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ahmed</LastName>
            <ForeName>Maliha</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Nephrology, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Love</LastName>
            <ForeName>Tanzy</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moore</LastName>
            <ForeName>Catherine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Nephrology, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Le</LastName>
            <ForeName>Thu H</ForeName>
            <Initials>TH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, Division of Nephrology, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jean-Gilles</LastName>
            <ForeName>Jerome</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, Division of Renal Pathology and Electron Microscopy, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goldman</LastName>
            <ForeName>Bruce</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, Division of Renal Pathology and Electron Microscopy, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Choung</LastName>
            <ForeName>Hae Yoon Grace</ForeName>
            <Initials>HYG</Initials>
            <Identifier Source="ORCID">0000-0002-1741-3173</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, Division of Renal Pathology and Electron Microscopy, University of Rochester Medical Center, Rochester, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ren Fail</MedlineTA>
        <NlmUniqueID>8701128</NlmUniqueID>
        <ISSNLinking>0886-022X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011507" MajorTopicYN="N">Proteinuria</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Lupus-like nephritis</Keyword>
        <Keyword MajorTopicYN="N">autoimmune disease</Keyword>
        <Keyword MajorTopicYN="N">full-house nephropathy</Keyword>
        <Keyword MajorTopicYN="N">lupus</Keyword>
        <Keyword MajorTopicYN="N">lupus nephritis</Keyword>
      </KeywordList>
      <CoiStatement>The authors have no conflicts of interest to declare. MA and HYC conceptualized, collected data, and wrote the first draft of the manuscript. TL performed statistical analysis. Formal analysis, writing review, and revisions were performed by all authors. All authors read and approved the final manuscript.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>31</Day>
          <Hour>12</Hour>
          <Minute>4</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35357272</ArticleId>
        <ArticleId IdType="pmc">PMC8979540</ArticleId>
        <ArticleId IdType="doi">10.1080/0886022X.2022.2057862</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Kudose S, Santoriello D, Bomback AS, et al. . 
Sensitivity and specificity of pathologic findings to diagnose lupus nephritis. Clin J Am Soc Nephrol. 2019;14(11):1605–1615.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6832038</ArticleId>
            <ArticleId IdType="pubmed">31653670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huerta A, Bomback AS, Liakopoulos V, et al. . 
Renal-limited ‘lupus-like’ nephritis. Nephrol Dial Transplant. 2012;27(6):2337–2342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22207326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hochberg MC.
Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9324032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan EM, Cohen AS, Fries JF, et al. . 
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–1277.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7138600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petri M, Orbai AM, Alarcon GS, et al. . 
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–2686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3409311</ArticleId>
            <ArticleId IdType="pubmed">22553077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wen YK, Chen ML.. 
Clinicopathological study of originally non-lupus “full-house” nephropathy. Ren Fail. 2010;32(9):1025–1030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20863204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rijnink EC, Teng YK, Kraaij T, et al. . 
Idiopathic non-lupus full-house nephropathy is associated with poor renal outcome. Nephrol Dial Transplant. 2017;32(4):654–662.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28340077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sam R, Joshi A, James S, et al. . 
Lupus-like membranous nephropathy: is it lupus or not?
Clin Exp Nephrol. 2015;19(3):395–402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24993947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruggiero B, Vivarelli M, Gianviti A, et al. . 
Outcome of childhood-onset full-house nephropathy. Nephrol Dial Transplant. 2017;32(7):1194–1204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27270291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gianviti A, Barsotti P, Barbera V, et al. . 
Delayed onset of systemic lupus erythematosus in patients with “full-house” nephropathy. Pediatr Nephrol. 1999;13(8):683–687.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10502127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rijnink EC, Teng YKO, Kraaij T, et al. . 
Validation of the systemic lupus international collaborating clinics classification criteria in a cohort of patients with full house glomerular deposits. Kidney Int. 2018;93(1):214–220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28950993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith EMD, Rasul S, Ciurtin C, et al. . 
Limited sensitivity and specificity of ACR/EULAR-2019 classification criteria for SLE in JSLE? - Observations from the UK JSLE cohort study. Rheumatology (Oxford). 2021;60:5271–5281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8566265</ArticleId>
            <ArticleId IdType="pubmed">33690793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haas M.
IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies. Am J Kidney Dis. 1994;23(3):358–364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8128936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haas M, Kaul S, Eustace JA.. 
HIV-associated immune complex glomerulonephritis with “lupus-like” features: a clinicopathologic study of 14 cases. Kidney Int. 2005;67(4):1381–1390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15780090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee HJ, Choi SY, Jeong KH, et al. . 
Association of C1q deposition with renal outcomes in IgA nephropathy. Clin Nephrol. 2013;80(2):98–104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23587123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sethi S, D’Costa MR, Hermann SM, et al. . 
Immune-complex glomerulonephritis following COVID-19 infection. Kidney Int Rep. 2021;6:1170–1173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7879058</ArticleId>
            <ArticleId IdType="pubmed">33615049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee LC, Lam KK, Lee CT, et al. . 
Full house” proliferative glomerulonephritis: an unreported presentation of subacute infective endocarditis. J Nephrol. 2007;20(6):745–749.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18046678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai FM, To KF, Wang AY, et al. . 
Hepatitis B virus-related nephropathy and lupus nephritis: morphologic similarities of two clinical entities. Mod Pathol. 2000;13(2):166–172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10697274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashour T, Nakhoul G, Patil P, et al. . 
Immune check point inhibitor-associated glomerulonephritis. Kidney Int Rep. 2019;4(2):355–359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6365371</ArticleId>
            <ArticleId IdType="pubmed">30775635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu KL, Wu MY, Wang CH, et al. . 
The role of immune checkpoint receptors in regulating immune reactivity in lupus. Cells. 2019;8(10):1213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6829486</ArticleId>
            <ArticleId IdType="pubmed">31597242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishimura H, Nose M, Hiai H, et al. . 
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999;11(2):141–151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10485649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strasma A, Coke H, Mamlouk O, et al. . 
Lupus-Like glomerulonephritis associated with regorafenib, a multikinase inhibitor. Kidney Med. 2021;3(2):294–298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8039408</ArticleId>
            <ArticleId IdType="pubmed">33851126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hogan JJ, Markowitz GS, Radhakrishnan J.. 
Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol. 2015;10(7):1300–1310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4491282</ArticleId>
            <ArticleId IdType="pubmed">26092827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stokes MB, D’Agati VD.. 
Full-house glomerular deposits: beware the sheep in wolf’s clothing. Kidney Int. 2018;93(1):18–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29291817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nangaku M, Couser WG.. 
Mechanisms of immune-deposit formation and the mediation of immune renal injury. Clin Exp Nephrol. 2005;9(3):183–191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16189625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burlingame RW, Cervera R.. 
Anti-chromatin (anti-nucleosome) autoantibodies. Autoimmun Rev. 2002;1(6):321–328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12848987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pisetsky DS.
Anti-DNA and autoantibodies. Curr Opin Rheumatol. 2000;12(5):364–368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10990170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Bavel CC, Fenton KA, Rekvig OP, et al. . 
Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 2008;58(7):1892–1899.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18576314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pirkle JL, Freedman BI, Fogo AB.. 
Immune complex disease with a lupus-like pattern of deposition in an antinuclear antibody-negative patient. Am J Kidney Dis. 2013;62(1):159–164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23548558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prendecki M, Clarke C, Cairns T, et al. . 
Anti-glomerular basement membrane disease during the COVID-19 pandemic. Kidney Int. 2020;98(3):780–781.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7318989</ArticleId>
            <ArticleId IdType="pubmed">32599088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uppal NN, Kello N, Shah HH, et al. . 
De novo ANCA-associated vasculitis with glomerulonephritis in COVID-19. Kidney Int Rep. 2020;5(11):2079–2083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7439090</ArticleId>
            <ArticleId IdType="pubmed">32839744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suso AS, Mon C, Onate Alonso I, et al. . 
IgA vasculitis with nephritis (Henoch-Schönlein Purpura) in a COVID-19 patient. Kidney Int Rep. 2020;5(11):2074–2078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7439008</ArticleId>
            <ArticleId IdType="pubmed">32839743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boils CL, Nasr SH, Walker PD, et al. . 
Update on endocarditis-associated glomerulonephritis. Kidney Int. 2015;87(6):1241–1249.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4455140</ArticleId>
            <ArticleId IdType="pubmed">25607109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heffner JE.
Extracardiac manifestations of bacterial endocarditis. West J Med. 1979;131(2):85–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1271697</ArticleId>
            <ArticleId IdType="pubmed">516715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Konstantinov KN, Ulff-Møller CJ, Tzamaloukas AH.. 
Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms. Autoimmun Rev. 2015;14(3):201–203.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25448042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarzi-Puttini P, Atzeni F, Capsoni F, et al. . 
Drug-induced lupus erythematosus. Autoimmunity. 2005;38(7):507–518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16373256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stokes MB, Foster K, Markowitz GS, et al. . 
Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant. 2005;20(7):1400–1406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15840673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vogt BA, Kim Y, Jennette JC, et al. . 
Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr. 1994;124(6):986–988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8201492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonzalez-Juanatey C, Gonzalez-Gay MA, Llorca J, et al. . 
Rheumatic manifestations of infective endocarditis in non-addicts. A 12-year study. Medicine (Baltimore). 2001;80(1):9–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11204504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang BG, Markowitz GS, Seshan SV, et al. . 
Renal manifestations of concurrent systemic lupus erythematosus and HIV infection. Am J Kidney Dis. 1999;33(3):441–449.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10070907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Couser WG, Johnson RJ.. 
The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int. 2014;86(5):905–914.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24621918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pyne D, Isenberg DA.. 
Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis. 2002;61(1):70–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1753864</ArticleId>
            <ArticleId IdType="pubmed">11779764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weetman AP, Walport MJ.. 
The association of autoimmune thyroiditis with systemic lupus erythematosus. Br J Rheumatol. 1987;26(5):359–361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3664160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kausman D, Isenberg DA.. 
Thyroid autoimmunity in systemic lupus erythematosus: the clinical significance of a fluctuating course. Br J Rheumatol. 1995;34(4):361–364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7788152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watad A, Mahroum N, Whitby A, et al. . 
Hypothyroidism among SLE patients: case-control study. Autoimmun Rev. 2016;15(5):484–486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26826435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santoro D, Vadalà C, Siligato R, et al. . 
Autoimmune thyroiditis and glomerulopathies. Front Endocrinol (Lausanne). 2017;8:119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5454061</ArticleId>
            <ArticleId IdType="pubmed">28626447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koçak G, Huddam B, Azak A, et al. . 
Coexistent findings of renal glomerular disease with hashimoto’s thyroiditis. Clin Endocrinol (Oxf). 2012;76(5):759–762.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22106873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aringer M, Costenbader K, Daikh D, et al. . 
2019 European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–1412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6827566</ArticleId>
            <ArticleId IdType="pubmed">31385462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weening JJ, D’Agati VD, Schwartz MM, et al. . 
The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521–530.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14717922</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
